Alhazmi Shaima Muhammed, Noor Samah Omar, Alshamrani Majid Mousa, Farahat Fayssal Mostafa
From the Faculty of Science, King Abdulaziz University, Jeddah, Saudi Arabia.
From the Infection Prevention and Control, King Abdulaziz Medical City, King Abdullah International Medical Research Center, King Saud bin Abdulaziz University for Health Sciences, Riyadh and Jeddah, Saudi Arabia.
Ann Saudi Med. 2019 Jul-Aug;39(4):258-264. doi: 10.5144/0256-4947.2019.258. Epub 2019 Aug 5.
Bloodstream infections (BSI) are a major complication of hemodialysis. The risk of infection among hemodialysis patients is usually associated with the dialysis procedure itself, specifically the means of vascular access.
Estimate the rate of BSI and assess factors possibly associated with BSI.
Analytical retrospective medical record review.
Hemodialysis unit in a tertiary care center.
Adult patients (18-60 years old) who had hemodialysis as first renal replacement therapy in the 20-month period from January 2014 to August 2016 were included in this study. Demographic and clinical characteristics were used in a multivariate logistic regression to assess factors that might be associated with BSI.
The rate of BSI and associated factors among chronic hemodialysis outpatients.
160 outpatients on hemodialysis, median (IQR) age 47.7 (37.0-56.0) years, males (60.6%).
The rate of BSI was 0.4 per 100 patient-months. Multivariate logistic regression revealed that patients who had central venous catheters had the highest risk for BSI (odds ratio: 10.088; 95% CI= 2.595-39.215; P=.001) compared with arteriovenous fistulas. Gram-negative bacteria were isolated in 54.6% of cases, with coagulase-negative Staphylococcus the most frequent isolate (18.2%), followed by Klebsiella pneumoniae and Enterobacteriaceae (15.2%, each).
The type of vascular access type is the main risk factor associated with BSI in hemodialysis patients. The arteriovenous fistula, which has a lower infection rate compared to the catheter, is the best available option for hemodialysis patients.
Retrospective, single center and relatively small sample size.
None.
血流感染(BSI)是血液透析的主要并发症。血液透析患者的感染风险通常与透析操作本身相关,特别是血管通路的方式。
估计BSI的发生率并评估可能与BSI相关的因素。
分析性回顾性病历审查。
三级医疗中心的血液透析单元。
本研究纳入了2014年1月至2016年8月期间以血液透析作为首次肾脏替代治疗的成年患者(18 - 60岁)。人口统计学和临床特征用于多因素逻辑回归分析,以评估可能与BSI相关的因素。
慢性血液透析门诊患者的BSI发生率及相关因素。
160例血液透析门诊患者,年龄中位数(四分位间距)为47.7(37.0 - 56.0)岁,男性占60.6%。
BSI发生率为每100患者月0.4例。多因素逻辑回归分析显示,与动静脉内瘘相比,使用中心静脉导管的患者发生BSI的风险最高(比值比:10.088;95%置信区间= 2.595 - 39.215;P = 0.001)。54.6%的病例分离出革兰阴性菌,凝固酶阴性葡萄球菌是最常见的分离菌株(18.2%),其次是肺炎克雷伯菌和肠杆菌科细菌(各占15.2%)。
血管通路类型是血液透析患者发生BSI的主要危险因素。与导管相比感染率较低的动静脉内瘘是血液透析患者的最佳选择。
回顾性研究、单中心且样本量相对较小。
无。